Scarica l'app Stockscreener
24.71
2.15%
0.52
Dopo l'orario di chiusura:
24.54
-0.17
-0.69%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DOCS Giù?
Forum
Previsione
Precedente Chiudi:
$24.19
Aprire:
$24.1
Volume 24 ore:
3.05M
Relative Volume:
0.69
Capitalizzazione di mercato:
$4.40B
Reddito:
$644.86M
Utile/perdita netta:
$196.05M
Rapporto P/E:
25.18
EPS:
0.9812
Flusso di cassa netto:
$317.50M
1 W Prestazione:
-8.82%
1M Prestazione:
-3.59%
6M Prestazione:
-0.28%
1 anno Prestazione:
-64.19%
Intervallo 1D:
$24.07
$25.04
Intervallo di 1 settimana:
$23.95
$27.03
Portata 52W:
$17.15
$76.51
Doximity Inc Stock (DOCS) Company Profile
Nome
Doximity Inc
Settore
Industria
Telefono
(650) 549-4330
Indirizzo
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, BTSG, TEM, TXG, HQY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
24.71 | 4.31B | 644.86M | 196.05M | 317.50M | 0.9812 |
VEEV
Veeva Systems Inc
|
260.98 | 42.23B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
57.88 | 12.27B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
58.74 | 11.13B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
66.38 | 8.77B | 638.78M | -22.66M | 122.18M | -0.1744 |
HQY
Healthequity Inc
|
94.55 | 7.66B | 1.34B | 230.70M | 440.96M | 2.6695 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-20 | Downgrade | Truist | Buy → Hold |
| 2026-04-08 | Downgrade | Evercore ISI | Outperform → In-line |
| 2026-02-09 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2026-02-06 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2026-01-20 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2026-01-09 | Iniziato | RBC Capital Mkts | Outperform |
| 2026-01-08 | Aggiornamento | Truist | Hold → Buy |
| 2025-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-11-21 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | Iniziato | BMO Capital Markets | Market Perform |
| 2025-10-27 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-10-10 | Downgrade | JP Morgan | Neutral → Underweight |
| 2025-10-01 | Downgrade | Goldman | Neutral → Sell |
| 2025-07-09 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-06-02 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2025-02-07 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | Iniziato | Stephens | Equal-Weight |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-11-15 | Iniziato | Goldman | Neutral |
| 2024-11-14 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-08-09 | Aggiornamento | Needham | Hold → Buy |
| 2024-07-18 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2024-01-02 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-08-09 | Downgrade | Guggenheim | Buy → Neutral |
| 2023-08-09 | Downgrade | Needham | Buy → Hold |
| 2023-08-03 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | Iniziato | Wells Fargo | Overweight |
| 2022-10-24 | Iniziato | Evercore ISI | In-line |
| 2022-10-13 | Iniziato | BTIG Research | Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-08-05 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-07-28 | Iniziato | Berenberg | Buy |
| 2022-05-18 | Reiterato | BofA Securities | Neutral |
| 2022-05-18 | Reiterato | Goldman | Buy |
| 2022-05-18 | Reiterato | Guggenheim | Buy |
| 2022-05-18 | Reiterato | Jefferies | Buy |
| 2022-05-18 | Reiterato | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Reiterato | Needham | Buy |
| 2022-04-07 | Iniziato | Guggenheim | Buy |
| 2022-04-04 | Iniziato | BofA Securities | Neutral |
| 2022-02-11 | Iniziato | Goldman | Buy |
| 2021-12-14 | Downgrade | JP Morgan | Neutral → Underweight |
| 2021-12-02 | Iniziato | Jefferies | Buy |
| 2021-11-17 | Iniziato | Robert W. Baird | Outperform |
| 2021-11-10 | Reiterato | Canaccord Genuity | Buy |
| 2021-11-10 | Reiterato | Goldman | Neutral |
| 2021-11-10 | Reiterato | Morgan Stanley | Equal-Weight |
| 2021-11-10 | Reiterato | Needham | Buy |
| 2021-11-10 | Reiterato | Piper Sandler | Overweight |
| 2021-08-26 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-07-19 | Iniziato | Canaccord Genuity | Buy |
| 2021-07-19 | Iniziato | Goldman | Neutral |
| 2021-07-19 | Iniziato | JP Morgan | Overweight |
| 2021-07-19 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Iniziato | Piper Sandler | Overweight |
| 2021-07-19 | Iniziato | Raymond James | Outperform |
| 2021-07-19 | Iniziato | SVB Leerink | Outperform |
| 2021-07-19 | Iniziato | William Blair | Outperform |
Mostra tutto
Doximity Inc Borsa (DOCS) Ultime notizie
Precision Trading with Doximity Inc. Class A (DOCS) Risk Zones - Stock Traders Daily
Doximity (NYSE:DOCS): Is the Growth Story Changing? - Kalkine Media
Doximity stock falls as Freedom Capital cuts to hold By Investing.com - Investing.com Australia
Doximity (NYSE:DOCS) Stock Rating Lowered by Freedom Capmkts - marketbeat.com
Doximity stock falls as Freedom Capital cuts to hold - Investing.com
Doximity stock rating cut to Hold by Freedom Capital on margin concerns - Investing.com Australia
Doximity, Inc. $DOCS Shares Sold by Carmignac Gestion - marketbeat.com
Doximity (NYSE:DOCS) Trading Down 7.1%Time to Sell? - marketbeat.com
Doximity stock downgraded at Freedom Capital (DOCS:NYSE) - Seeking Alpha
DOCS Downgraded by Freedom Capital Markets -- Price Target Raised to $27.00 - GuruFocus
Why is Doximity stock slipping today? By Investing.com - Investing.com Canada
Doximity (NYSE:DOCS): Is the Inflation Test Bigger Than It Looks? - Kalkine Media
Doximity, Inc. (DOCS) Stock Analysis: Navigating a 13% Potential Upside Amidst Healthcare Innovation - DirectorsTalk Interviews
Why GitLab Stock Soared 35% in August and Why It's Already Rocketed Higher - The Motley Fool
Doximity, Inc. (DOCS) Stock Analysis: Navigating a 17.56% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
ถึงเวลาพิจารณาเข้าซื้อหุ้น Doximity, Inc. (NYSE:DOCS) แล้วหรือยัง? - Moomoo
AXQ Capital LP Has $3.67 Million Stake in Doximity, Inc. $DOCS - marketbeat.com
Doximity, Inc. $DOCS Shares Purchased by Wellington Management Group LLP - marketbeat.com
Doximity (DOCS) 10K Form and Latest SEC Filings 2026 - marketbeat.com
Could Doximity (NYSE:DOCS) Gain Focus Within the NYSE Composite? - Kalkine Media
Doximity (NYSE:DOCS): A Quality Investment with Superior Returns on Capital - ChartMill
Director at Doximity (NYSE: DOCS) lines up 2,000-share sale - Stock Titan
3 Reasons to Avoid DOCS and 1 Stock to Buy Instead - Yahoo Finance
Doximity (NYSE:DOCS) Shares Gap DownTime to Sell? - marketbeat.com
Doximity, Inc. (DOCS): Investor Outlook Reveals 11.40% Potential Upside Amidst Strong Market Dynamics - DirectorsTalk Interviews
Fundsmith LLP Has $13.55 Million Stake in Doximity, Inc. $DOCS - marketbeat.com
Doximity (DOCS) Is Up 5.5% After AI Optimism Lifts Enterprise SaaS Peers' Results What's Changed - Sahm
Doximity Inc (DOCS) Shares Surge 4.5% -- What GF Score of 86 Tel - GuruFocus
Doximity (NYSE:DOCS) Trading Up 4.5%What's Next? - MarketBeat
Doximity Inc (DOCS) Shares Surge 3.4% -- What GF Score of 82 Tel - GuruFocus
Amplitude, GitLab, Doximity, Freshworks, and Sprinklr Shares Skyrocket, What You Need To Know - TradingView
Odyssean LLC Invests $2.38 Million in Doximity, Inc. $DOCS - MarketBeat
Doximity (NYSE: DOCS) director to sell 2,000 shares in 2026 - Stock Titan
Nearly Half of Doctors Say They May Quit Within 2 Years. New Tools Are Helping Ease Burnout - inc.com
Reasons to Retain Doximity Stock in Your Portfolio for Now - Yahoo Finance
Doximity, Inc. (NYSE:DOCS) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Doximity (NYSE:DOCS) Given New $27.00 Price Target at Barclays - MarketBeat
A Doximity Director Moved 7,500 Shares the Day the Stock Popped 33%. Here's What to Know - AOL.com
DOXIMITY : BARCLAYS RAISES TARGET PRICE TO $27 FROM $20 - Bitget
Doximity (DOCS) Latest Quarter: Profit Per Share Falls Below Its Benchmark at the Close; Stock Move: The Market Price Moves 3.25% Higher in Latest TradingRevenue Guidance Update - Vinanet
Doximity (DOCS) Latest Quarter: Profit Per Share Falls Below Its Benchmark at the Close; Stock Move - Vinanet
SK Hynix, SpaceX, Doximity, Trade Desk, Rigetti, Coherent, and More Stocks That Explain Today's Market -- Barrons.com - Moomoo
Doximity (DOCS) Results Breakdown: EPS Does Not Reach the Reported Estimate in the Reported Period; Post-Report: Shares Rise 3.25% on the DayEarnings Beat Streak - Vinanet
Doximity (DOCS) Stock Looks Cheap On Cash Flow Yet Fair On Earnings - Yahoo Finance
Doximity (DOCS) Stock Could Be 31% Undervalued Following Raised AI Outlook - simplywall.st
Doximity (DOCS) Q1 2027 Earnings Call Transcript - AOL.com
Doximity (DOCS) Could Be 26% Below Fair Value On Strong Earnings Guidance - Yahoo Finance
Doximity (NYSE:DOCS) Valuation Debate Gets More Interesting - Kalkine Media
What Investors Should Know of This Doximity Officer's Latest Insider Transaction - The Motley Fool
Doximity Handed Its President 150,000 Options Last Month. Here's What the Latest Filing Signals for Investors - The Motley Fool
Doximity's New CFO Just Filed His First Form 4. Here's What Long-Term Investors Should Know. - The Motley Fool
Doximity Inc Azioni (DOCS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.35%
2.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):